People | June 06, 2026
Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets
Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals
The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
